Showing results (1-10 of 1,197) with videos related to
Sort By:
Pageof 120
Experimental Oncology|January 13, 2006
Evaluation of fluorenhymustine as a rationally designed novel anticancer agentS Samanta, A Pain, M Ghosh, et al.Journal of Experimental & Clinical Cancer Research : CR|June 20, 2002
Evaluation of naphthal-NU, a 2-chloroethylnitrosourea derivative of naphthalimide, as a mixed-function anticancer agentS Samanta, A Pain, S Dutta, et al.Acta Poloniae Pharmaceutica|March 6, 2002
Synthesis and evaluation of 2-chloroethylnitrosoureas of substituted naphthalimides as mixed-function anticancer compoundsS Samanta, A Pain, S Dutta, et al.Neoplasma|December 29, 1999
Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)hydrazines as anticancer agentsM Ghosh, S Dutta, U SanyalActa Poloniae Pharmaceutica|January 13, 2004
Synthesis and evaluation of substituted naphthalimide nitrogen mustards as rationally designed anticancer compoundsA Pain, S Samanta, S Dutta, et al.Journal of Experimental & Clinical Cancer Research : CR|October 30, 2003
Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agentA Pain, S Samanta, S Dutta, et al.Cancer Letters|May 18, 2000
Evaluation of dimethylaminosulfonates of alkane diols as a novel group of anticancer agentsU Sanyal, R Nanda, S Samanta, et al.Neoplasma|January 1, 1996
Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180S Bhattacharya, M Ghosh, U Sadhu, et al.Cancer Letters|April 1, 2008
Evaluation of beta-tethymustine, a new anticancer compound, in murine tumour modelsM Ghosh, S Bhattacharya, U Sadhu, et al.Cancer Letters|June 15, 1993
Evaluation of 'cypenhymustine', a new anticancer compound, in murine tumour modelsU Sanyal, S Bhattacharya, U Sadhu, et al.Pageof 120